Clobazam Suspension
Product Images NDC 67877-658

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clobazam (NDC 67877-658). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ascend Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Clo-fig-a.jpg (Clo Fig A)

Clobazam Oral Suspension 2.5 mg/mL in a 120 mL bottle, labeled for oral administration only by Ascend Laboratories, LLC. The image shows the brown glass bottle with a white cap, a bottle adapter, and two blue oral syringes. The packaging displays dosage information and prescription instructions.*

FDA Label Image

Clo-fig-b.jpg (Clo Fig B)

Clobazam Oral Suspension 2.5 mg/mL in a brown glass bottle with a white child-resistant cap. The label shows the product name, strength, and indicates it is for oral administration only. The labeler is Ascend Laboratories, LLC. The image also instructs to shake well before use.*

FDA Label Image

Clo-fig-d.jpg (Clo Fig D)

An instructional diagram of a dosing syringe for oral suspension, labeled to show the tip, dosage indicators on the barrel, edge of the plunger, barrel, and the plunger itself. The syringe is used for measuring liquid medication doses.*

FDA Label Image

Clo-fig-e.jpg (Clo Fig E)

The image shows a bottle of Clobazam oral suspension with a strength of 2.5 mg/mL by Ascend Laboratories, LLC. A blue measuring syringe is inserted into the open bottle's neck for dosing. The label on the dark bottle is partially visible, showing the product name, dosage form, and strength.*

FDA Label Image

Clo-fig-f.jpg (Clo Fig F)

An instructional image showing a hand measuring a blue oral suspension using a clear dosing syringe marked with 1 to 10 mL volume increments. The syringe is attached to a brown glass bottle being held upside down.*

FDA Label Image

Clo-fig-g.jpg (Clo Fig G)

A close-up image showing a brown bottle dispensing blue liquid into a transparent oral syringe marked with volume measurements from 1 to 10 mL. An annotation indicates to measure to the edge of the syringe plunger, illustrating how to accurately measure the dose of liquid medication.*

FDA Label Image

Clo-fig-h.jpg (Clo Fig H)

An illustration showing a close-up of a child receiving an oral medication using a blue dosing syringe held by an adult hand. The syringe has measurement markings on its transparent barrel and a protective cap at the tip, indicating oral administration of a liquid suspension.*

FDA Label Image

Clo-fig-i.jpg (Clo Fig I)

Clobazam oral suspension 2.5 mg/mL in an amber glass bottle with a white child-resistant cap. The label shows the product name Clobazam Oral Suspension and the National Drug Code (NDC) 67877-658-61. The bottle is held by a hand demonstrating how to twist off the cap.*

FDA Label Image

Structure (Clo01)

Chemical structure of clobazam showing a benzodiazepine core with chlorine substitution on the benzene ring, a methyl group attached to nitrogen, and two ketone groups on the diazepine ring, along with a phenyl group attached to another nitrogen.*

FDA Label Image

Clo02.jpg (Clo02)

A bar chart illustrating the percent reduction in weekly drop seizure rate comparing placebo and three dosage groups labeled Low, Medium, and High. The y-axis represents percent reduction, with values from 0 to -80%. Numerical values are shown above each bar, showing progressively greater reduction from placebo (-12.1%) to high dose (-68.3%). Sample sizes are indicated below each group.*

FDA Label Image

Clo03.jpg (Clo03)

A bar chart depicting the proportion of patients (percentage) experiencing different ranges of reduction in weekly drop seizure frequency from baseline. The chart compares four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High, showing varying effectiveness across the reduction percentage categories.*

FDA Label Image

Clo06.jpg (Clo06)

Illustration showing the placement of a dropper or dosing cap onto a bottle neck, indicated by a downward arrow. The image is likely part of instructions for use or assembly for Clobazam oral suspension packaging.*

FDA Label Image

Clo16.jpg (Clo16)

The packaging label for Clobazam Oral Suspension 2.5 mg/mL features a white and purple color scheme. It includes the NDC 67877-658, dosage form (oral suspension), and volume of 120 mL. The label indicates it is for oral administration only and is distributed by Ascend Laboratories, LLC. Additional storage and usage instructions are provided.*

FDA Label Image

Clo17.jpg (Clo17)

Label for Clobazam Oral Suspension 2.5 mg/mL by Ascend Laboratories, LLC. The 120 mL bottle label includes active ingredient amount per mL, storage instructions, prescription-only status, manufacturer and distributor information, and a barcode. It is for oral administration and contains usage guidance.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.